register

News - Biotechnology

State-based biotech associations sign MOU

Health Industry Hub | February 26, 2024 |

Biotech News: With a goal towards fostering collaboration and support within the biotech sector, BioNSW has announced a Memorandum of Understanding (MOU) with state industry associations BioMelbourne Network and Life Sciences Queensland (LSQ). This development has been welcomed by the biotech industry.

The strategic partnership is the result of the efforts put forth by LSQ’s Dr Erin Evans, BioMelbourne’s Jeff Malone, and BioNSW’s Dr Brad Walsh and Anthony Murray.

Mr Malone, CEO at BioMelbourne Network, who is set to leave the organisation on 1 March, expressed his optimism about the collaboration, stating “This MOU is not the beginning of our collaboration and support; it reflects the work we’ve been developing over the past year with trade missions, events, and other advocacy activities. Stronger together.”

BioNSW, launched in August 2023, aims to address a notable gap in the local biotech sector that the national peak body AusBiotech was unable to fulfil.

The non-for-profit organisation recently hosted a MedTech delegation, led by Governor Tim Walz from The Department of Employment & Economic Development of the Minnesota Trade Office. Minnesota, a recognised centre of health innovation, boasts the number one health technology cluster globally, including industry giant Medtronic. This delegation served as a platform for fostering innovation partnerships and strengthening ties between Minnesotan and Australian biotech companies.

Minnesota is also among 31 tech hubs designated by the Biden administration. Peter Frosch, President and CEO of Greater MSP (Minneapolis-St. Paul region), told Health Industry Hub that he credited this achievement to the Minnesota MedTech Hub 3.0 propelled by Geoff Martha, Medtronic’s global Chairman and CEO, and a coalition of major players in the medical technology landscape.

While the biotech MOU underscores a commitment to advance state-based activities, AusBiotech remains the peak national body driving policy outcomes for the biotech sector.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - MedTech & Diagnostics

Hearts4heart takes aim at private system leaving patients to pay the price

Hearts4heart takes aim at health insurers leaving patients to pay the price

Health Industry Hub | September 4, 2026 |

Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]

More


News - MedTech & Diagnostics

Queensland first: Private hospital deploys Abbott's PFA in atrial fibrillation

Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation

Health Industry Hub | September 4, 2026 |

More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]

More


News - Pharmaceuticals

Five years of HTA reform talk, Now comes the $47 billion question

Five years of HTA reform talk, now comes the $47 billion question

Health Industry Hub | September 4, 2026 |

Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]

More


News - Pharmaceuticals

New MFN deals raise the stakes for Australia’s delayed HTA reform

New MFN deals raise the stakes for Australia’s delayed HTA reform

Health Industry Hub | September 2, 2026 |

Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]

More


This content is copyright protected. Please subscribe to gain access.